CADEN, NCT00953420: Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes |
|
|
| Completed | 2 | 20 | US | Docetaxel, Taxotere, Carboplatin, Paraplatin, Dexamethasone, Decadron, EBV-specific cytotoxic T lymphocytes, EBV-specific cytotoxic T lymphocytes 1 x 10e8 cells/m2 IV, G-CSF or Peg-GCSF, Filgrastim or pegylated filgrastim | Baylor College of Medicine, The Methodist Hospital Research Institute, Center for Cell and Gene Therapy, Baylor College of Medicine, M.D. Anderson Cancer Center | Nasopharyngeal Carcinoma | 06/14 | 07/15 | | |
